Wellesley Pharmaceuticals Company
Wellesley Pharmaceuticals ensures that the ability of Nocturol to reduce and sometimes eliminate nocturia symptoms can be disseminated.
Employee Number:
1-10
Funding Status:
Late Stage Venture
Headquarters:
Newtown, Pennsylvania, United States
Technology:
Anti-infective Drugs
Estimated Revenue:
$1M to $10M
Founded Date:
2011
Industry:
PharmTech